Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The surmountable effect of FSCPX, an irreversible A(1) adenosine receptor antagonist, on the negative inotropic action of A(1) adenosine receptor full agonists in isolated guinea pig left atria.
Gesztelyi R, Kiss Z, Wachal Z, Juhasz B, Bombicz M, Csepanyi E, Pak K, Zsuga J, Papp C, Galajda Z, Branzaniuc K, Porszasz R, Szentmiklosi AJ, Tosaki A. Gesztelyi R, et al. Among authors: galajda z. Arch Pharm Res. 2013 Mar;36(3):293-305. doi: 10.1007/s12272-013-0056-z. Epub 2013 Feb 28. Arch Pharm Res. 2013. PMID: 23456693
The Janus face of adenosine: antiarrhythmic and proarrhythmic actions.
Szentmiklosi AJ, Galajda Z, Cseppento Á, Gesztelyi R, Susán Z, Hegyi B, Nánási PP. Szentmiklosi AJ, et al. Among authors: galajda z. Curr Pharm Des. 2015;21(8):965-76. doi: 10.2174/1381612820666141029100346. Curr Pharm Des. 2015. PMID: 25354187 Review.
Histamine and H1 -histamine receptors faster venous circulation.
Galajda Z, Balla J, Szentmiklosi AJ, Biro T, Czifra G, Dobrosi N, Cseppento A, Patonay L, Roszer T, Balla G, Popescu LM, Lekli I, Tosaki A. Galajda Z, et al. J Cell Mol Med. 2011 Dec;15(12):2614-23. doi: 10.1111/j.1582-4934.2010.01254.x. J Cell Mol Med. 2011. PMID: 21199332 Free PMC article.
Differences in angiotensin convertase enzyme (ACE) activity and expression may contribute to shorter event free period after coronary artery bypass graft surgery.
Daragó A, Fagyas M, Siket IM, Facskó A, Megyesi Z, Kalász J, Galajda Z, Szerafin T, Hársfalvi J, Edes I, Papp Z, Tóth A, Szentmiklósi J. Daragó A, et al. Among authors: galajda z. Cardiovasc Ther. 2012 Jun;30(3):136-44. doi: 10.1111/j.1755-5922.2010.00252.x. Epub 2010 Nov 25. Cardiovasc Ther. 2012. PMID: 21106034 Free article.
46 results